0001237899-20-000027.txt : 20200629
0001237899-20-000027.hdr.sgml : 20200629
20200629160850
ACCESSION NUMBER: 0001237899-20-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200629
FILED AS OF DATE: 20200629
DATE AS OF CHANGE: 20200629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SING GEORGE L
CENTRAL INDEX KEY: 0001225471
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20997567
MAIL ADDRESS:
STREET 1: LANCET CAPITAL
STREET 2: 45 ROCKEFELLER PLAZA STE 2008
CITY: NEW YORK
STATE: NY
ZIP: 10111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-06-29
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001225471
SING GEORGE L
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2020-06-29
4
S
0
500
609.37
D
1650
I
by Spouse
Common Stock
2020-06-29
4
S
0
200
606.8
D
2200
I
by Spouse/Cust Son
Common Stock
2020-06-29
4
S
0
200
607.54
D
2000
I
by Spouse/Cust Son
Common Stock
2020-06-29
4
S
0
500
608.29
D
1500
I
by Spouse/Cust Son
Common Stock
2020-06-29
4
S
0
100
609.68
D
1400
I
by Spouse/Cust Son
Common Stock
2020-06-29
4
S
0
1500
609.37
D
6200
I
by Trust for Son
Common Stock
115415
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 200 shares of Company stock on June 29, 2020 at prices ranging from $606.69 to $606.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 29, 2020 at each separate price.
Represents volume-weighted average price of sales of 500 shares of Company stock on June 29, 2020 at prices ranging from $608.14 to $608.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 29, 2020 at each separate price.
Represents volume-weighted average price of sales of 100 shares of Company stock on June 29, 2020 at prices ranging from $609.65 to $609.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 29, 2020 at each separate price.
/s/**George L. Sing
2020-06-29